A @SciImmunology study in mice suggests that targeting a gene linked to prostate tumorigenesis can make the disease more responsive to immunotherapy including adoptive T cell therapy, immune checkpoint blockade, and CXCR2 inhibition.
📄: https://t.co/mts2llwzaS https://t.co/KNACxGXBbz
This was tweeted by Science Magazine.